Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
Identifieur interne : 001883 ( Main/Curation ); précédent : 001882; suivant : 001884Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
Auteurs : Laureen Dartois [France] ; Guy Fagherazzi [France] ; Laura Baglietto [Australie] ; Marie-Christine Boutron-Ruault [France] ; Suzette Delaloge [France] ; Sylvie Mesrine [France] ; Françoise Clavel-Chapelon [France]Source :
- International journal of cancer [ 1097-0215 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, France (épidémiologie), Humains, Marqueurs biologiques tumoraux, Post-ménopause, Préménopause, Récepteur ErbB-2 (métabolisme), Récepteurs des oestrogènes (métabolisme), Récepteurs à la progestérone (métabolisme), Sujet âgé, Surveillance de la population, Tumeurs du sein (métabolisme), Tumeurs du sein (épidémiologie), Études de cohortes, Études de suivi, Études prospectives.
- MESH :
- métabolisme : Récepteur ErbB-2, Récepteurs des oestrogènes, Récepteurs à la progestérone, Tumeurs du sein.
- épidémiologie : France, Tumeurs du sein.
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Marqueurs biologiques tumoraux, Post-ménopause, Préménopause, Sujet âgé, Surveillance de la population, Études de cohortes, Études de suivi, Études prospectives.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Adult, Aged, Biomarkers, Tumor, Breast Neoplasms (epidemiology), Breast Neoplasms (metabolism), Cohort Studies, Female, Follow-Up Studies, France (epidemiology), Humans, Middle Aged, Population Surveillance, Postmenopause, Premenopause, Prospective Studies, Receptor, ErbB-2 (metabolism), Receptors, Estrogen (metabolism), Receptors, Progesterone (metabolism), Risk Factors.
- MESH :
- chemical , metabolism : Receptor, ErbB-2, Receptors, Estrogen, Receptors, Progesterone.
- chemical : Biomarkers, Tumor.
- geographic , epidemiology : France.
- epidemiology : Breast Neoplasms.
- metabolism : Breast Neoplasms.
- Adult, Aged, Cohort Studies, Female, Follow-Up Studies, Humans, Middle Aged, Population Surveillance, Postmenopause, Premenopause, Prospective Studies, Risk Factors.
Abstract
Breast cancer is the most frequently diagnosed cancer among women worldwide. Breast cancer risk factors have been widely explored individually; however, little is known about their combined impact. We included 67,634 women from the French E3N prospective cohort, aged 42-72 at baseline. During a 15-year follow-up period, 497 premenopausal and 3,138 postmenopausal invasive breast cancer cases were diagnosed. Population-attributable fractions (PAFs) were used to estimate cases proportions attributable to risk factors under hypothetical scenarios of lowest exposure. We examined overall premenopausal and postmenopausal invasive breast cancers and tumour subtypes (ER status and HER2 expression). Premenopausal breast cancer was not significantly attributable to non-behavioral (61.2%, -15.5 to 91.88%) nor to behavioral (39.9%, -71.0 to 93.9%) factors, contrary to postmenopausal breast cancer (41.9%, 4.5 to 68.7% and 53.5%, 12.8 to 78.7%, respectively). Individually, the highest statistically significant PAFs were obtained in premenopause for birth weight (33.6%, 5.7 to 56.6%) and age at menarche (19.8%, 5.2 to 33.6%) for non-behavioral factors and in postmenopause for history of benign breast diseases (14.9%, 11.6 to 18.0%) and age at menarche (9.7%, 3.9 to 15.5%) for non-behavioral factors and for body shape at menarche (17.1%, 9.7 to 24.3%), use of hormone replacement therapy (14.5%, 9.2 to 19.6%), dietary pattern (10.1%, 2.6 to 17.4%) and alcohol consumption (5.6%, 1.9 to 9.3%) for behavioral factors. These proportions were higher for ER+, HER2- and ER+/HER2- postmenopausal breast cancers. Our data support the hypothesis that in postmenopause, never starting unhealthy behaviors can reduce the number of diagnosed breast cancers.
DOI: 10.1002/ijc.29987
PubMed: 26756677
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E93
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001E69
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001E69
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002F77
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :002F77
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002F77
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001878
Links to Exploration step
pubmed:26756677Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.</title>
<author><name sortKey="Dartois, Laureen" sort="Dartois, Laureen" uniqKey="Dartois L" first="Laureen" last="Dartois">Laureen Dartois</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fagherazzi, Guy" sort="Fagherazzi, Guy" uniqKey="Fagherazzi G" first="Guy" last="Fagherazzi">Guy Fagherazzi</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baglietto, Laura" sort="Baglietto, Laura" uniqKey="Baglietto L" first="Laura" last="Baglietto">Laura Baglietto</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Boutron Ruault, Marie Christine" sort="Boutron Ruault, Marie Christine" uniqKey="Boutron Ruault M" first="Marie-Christine" last="Boutron-Ruault">Marie-Christine Boutron-Ruault</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Delaloge, Suzette" sort="Delaloge, Suzette" uniqKey="Delaloge S" first="Suzette" last="Delaloge">Suzette Delaloge</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Gustave Roussy, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Medical Oncology, Gustave Roussy, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mesrine, Sylvie" sort="Mesrine, Sylvie" uniqKey="Mesrine S" first="Sylvie" last="Mesrine">Sylvie Mesrine</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Clavel Chapelon, Francoise" sort="Clavel Chapelon, Francoise" uniqKey="Clavel Chapelon F" first="Françoise" last="Clavel-Chapelon">Françoise Clavel-Chapelon</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26756677</idno>
<idno type="pmid">26756677</idno>
<idno type="doi">10.1002/ijc.29987</idno>
<idno type="wicri:Area/PubMed/Corpus">001E93</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E93</idno>
<idno type="wicri:Area/PubMed/Curation">001E69</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E69</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001E69</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E69</idno>
<idno type="wicri:Area/Ncbi/Merge">002F77</idno>
<idno type="wicri:Area/Ncbi/Curation">002F77</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002F77</idno>
<idno type="wicri:Area/Main/Merge">001878</idno>
<idno type="wicri:Area/Main/Curation">001883</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.</title>
<author><name sortKey="Dartois, Laureen" sort="Dartois, Laureen" uniqKey="Dartois L" first="Laureen" last="Dartois">Laureen Dartois</name>
<affiliation wicri:level="3"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fagherazzi, Guy" sort="Fagherazzi, Guy" uniqKey="Fagherazzi G" first="Guy" last="Fagherazzi">Guy Fagherazzi</name>
<affiliation wicri:level="3"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baglietto, Laura" sort="Baglietto, Laura" uniqKey="Baglietto L" first="Laura" last="Baglietto">Laura Baglietto</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Boutron Ruault, Marie Christine" sort="Boutron Ruault, Marie Christine" uniqKey="Boutron Ruault M" first="Marie-Christine" last="Boutron-Ruault">Marie-Christine Boutron-Ruault</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Delaloge, Suzette" sort="Delaloge, Suzette" uniqKey="Delaloge S" first="Suzette" last="Delaloge">Suzette Delaloge</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Gustave Roussy, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Medical Oncology, Gustave Roussy, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mesrine, Sylvie" sort="Mesrine, Sylvie" uniqKey="Mesrine S" first="Sylvie" last="Mesrine">Sylvie Mesrine</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Clavel Chapelon, Francoise" sort="Clavel Chapelon, Francoise" uniqKey="Clavel Chapelon F" first="Françoise" last="Clavel-Chapelon">Françoise Clavel-Chapelon</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805</wicri:regionArea>
<wicri:noRegion>94805</wicri:noRegion>
<wicri:noRegion>94805</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of cancer</title>
<idno type="eISSN">1097-0215</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Biomarkers, Tumor</term>
<term>Breast Neoplasms (epidemiology)</term>
<term>Breast Neoplasms (metabolism)</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>France (epidemiology)</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Population Surveillance</term>
<term>Postmenopause</term>
<term>Premenopause</term>
<term>Prospective Studies</term>
<term>Receptor, ErbB-2 (metabolism)</term>
<term>Receptors, Estrogen (metabolism)</term>
<term>Receptors, Progesterone (metabolism)</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>France (épidémiologie)</term>
<term>Humains</term>
<term>Marqueurs biologiques tumoraux</term>
<term>Post-ménopause</term>
<term>Préménopause</term>
<term>Récepteur ErbB-2 (métabolisme)</term>
<term>Récepteurs des oestrogènes (métabolisme)</term>
<term>Récepteurs à la progestérone (métabolisme)</term>
<term>Sujet âgé</term>
<term>Surveillance de la population</term>
<term>Tumeurs du sein (métabolisme)</term>
<term>Tumeurs du sein (épidémiologie)</term>
<term>Études de cohortes</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Receptor, ErbB-2</term>
<term>Receptors, Estrogen</term>
<term>Receptors, Progesterone</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Biomarkers, Tumor</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Récepteur ErbB-2</term>
<term>Récepteurs des oestrogènes</term>
<term>Récepteurs à la progestérone</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>France</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Population Surveillance</term>
<term>Postmenopause</term>
<term>Premenopause</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Marqueurs biologiques tumoraux</term>
<term>Post-ménopause</term>
<term>Préménopause</term>
<term>Sujet âgé</term>
<term>Surveillance de la population</term>
<term>Études de cohortes</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Breast cancer is the most frequently diagnosed cancer among women worldwide. Breast cancer risk factors have been widely explored individually; however, little is known about their combined impact. We included 67,634 women from the French E3N prospective cohort, aged 42-72 at baseline. During a 15-year follow-up period, 497 premenopausal and 3,138 postmenopausal invasive breast cancer cases were diagnosed. Population-attributable fractions (PAFs) were used to estimate cases proportions attributable to risk factors under hypothetical scenarios of lowest exposure. We examined overall premenopausal and postmenopausal invasive breast cancers and tumour subtypes (ER status and HER2 expression). Premenopausal breast cancer was not significantly attributable to non-behavioral (61.2%, -15.5 to 91.88%) nor to behavioral (39.9%, -71.0 to 93.9%) factors, contrary to postmenopausal breast cancer (41.9%, 4.5 to 68.7% and 53.5%, 12.8 to 78.7%, respectively). Individually, the highest statistically significant PAFs were obtained in premenopause for birth weight (33.6%, 5.7 to 56.6%) and age at menarche (19.8%, 5.2 to 33.6%) for non-behavioral factors and in postmenopause for history of benign breast diseases (14.9%, 11.6 to 18.0%) and age at menarche (9.7%, 3.9 to 15.5%) for non-behavioral factors and for body shape at menarche (17.1%, 9.7 to 24.3%), use of hormone replacement therapy (14.5%, 9.2 to 19.6%), dietary pattern (10.1%, 2.6 to 17.4%) and alcohol consumption (5.6%, 1.9 to 9.3%) for behavioral factors. These proportions were higher for ER+, HER2- and ER+/HER2- postmenopausal breast cancers. Our data support the hypothesis that in postmenopause, never starting unhealthy behaviors can reduce the number of diagnosed breast cancers.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001883 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001883 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:26756677 |texte= Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:26756677" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |